Search

everythinglearnresearchcommunity

for

Search:↓

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

High mTORC1 activity slows hair growth and causes it to lose color.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Rats can develop an immune response to prion protein peptides, but it may cause severe skin issues in older rats.

ILC1 cells contribute to hair loss in alopecia areata.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Hair follicles could help develop eye treatments by studying immune responses.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

A genetic marker linked to a type of hair loss was found in most patients studied.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Skin bacteria can help wound healing by activating certain immune cells.

Two mouse mutations cause similar hair loss despite different skin changes.